Delivery Order SPE2DB22D1041-SPE2DB25FUAA9
Award Date
3/26/25
Potential Completion Date
3/27/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,124.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYCOPHENOLATE 500 MG TABLET 500S, a pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,308.08 Firm Fixed Price Delivery Order contract is for the supply of 4567331014 - MYCOPHENOLATE 500 MG TABLET 500S, with a completion date of February 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $1,180.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of MYCOPHENOLATE 500 MG VIALS, a pharmaceutical product, with a performance period through February 18, 2025. The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award, valued at $4,966.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYCOPHENOLATE 200 MG/ML SUSP 160ML, a pharmaceutical product, to support military healthcare programs. The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,544.52, is a Firm Fixed Price Delivery Order for the supply of Mycophenolate 500 mg tablets. The contract has an ultimate completion date of March 25, 2025 and was awarded on March 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,331.60, is for the delivery of Mycophenolate 500 mg tablets. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of MYCOPHENOLATE 200 MG/ML SUSP 160ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $1,679.29. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of June 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide MYCOPHENOLIC ACID DR 360 MG TB 120S, a pharmaceutical product. The $1,246.77 firm fixed-price delivery order has a completion date of January 23, 2025 and is not designated as a set-aside contract. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a comprehensive range of...
This federal contract award, valued at $8,456.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mycophenolate 200 mg/ml suspension, a specialty medication, to support federal healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the delivery of Mycophenolate 200 mg/ml suspension in 160 ml bottles. The contract, valued at $7,014.89, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order with a completion date of December 27, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite...